Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 4Phase 4 2Phase 3 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Influenza, Human 4Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Patient Acceptance of Health Care 1Lymphoma, Non-Hodgkin 1Leukemia 1Infections 1Hematologic Neoplasms 1Healthy, no Evidence of Disease 1Health Behavior 1Colorectal Neoplasms 1COVID-19 1

Interventions

Influenza Vaccines 4vaxigrip 1influvac 1Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Influenza, Human × Influenza Vaccines × Clear all
NCT06124131 2025-05-04

BENEFIT-C

Tulane University

Phase NA Completed
50 enrolled 15 charts
Gastrointestinal

Vaccine-Preventable Diseases, COVID-19, Vaccination Hesitancy, Influenza, Human, Patient Acceptance of Health Care, Colorectal Neoplasms, Health Behavior

NCT03590808 2019-09-19

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

Seoul National University Hospital

Phase NA Completed
143 enrolled

Influenza, Human

NCT01215981 2017-12-28

Influenza Vaccine Post Allogeneic Transplant

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
68 enrolled 6 charts
Other hematologic neoplasm

Influenza, Human, Hematologic Neoplasms

NCT01707628 2014-01-31

Rituxivac

St. Antonius Hospital

Phase NA Completed
98 enrolled
Lymphoid

Influenza, Human, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡